Physician profile
Manjit K Risam
NPI 1306830047
$967.81
in general payments reported to CMS, 2019-2025
20 companies · $135 in 2025
The $135 reported for 2025 was less than what a typical Gynecology provider received nationally (typical 2025 total: $162).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $44.58 · 2020: $65.05 · 2021: $198 · 2022: $374 · 2023: $104 · 2024: $48.23 · 2025: $135.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $287.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $286.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $241.17 | 2020-2025 | Lo Loestrin Fe, Orilissa |
| Aspira Women'S Health INC | $106.92 | 2022 | |
| Coopersurgical, INC. | $81.16 | 2019-2025 | Paragard T 380a |
| Astellas Pharma US INC | $78.15 | 2023-2025 | Veozah |
| Organon LLC | $73.78 | 2024-2025 | Nexplanon |
| Evofem Biosciences, INC. | $58.07 | 2021-2022 | |
| Pfizer INC. | $57.26 | 2021-2023 | |
| Avion Pharmaceuticals | $41.14 | 2021-2022 | |
| Mayne Pharma Commercial LLC | $31.07 | 2021 | |
| Mylan Pharmaceuticals INC. | $26.97 | 2021 | |
| Therapeuticsmd, INC. | $24.83 | 2020 | |
| Mission Pharmacal Company | $22.66 | 2019 | |
| Supernus Pharmaceuticals, INC. | $21.05 | 2025 | Qelbree |
| Sage Therapeutics, LLC | $21.05 | 2025 | Zurzuvae |
| Myovant Sciences INC. | $17.76 | 2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exeltis, USA INC. | $14.08 | 2022 | |
| Dysis Medical, INC. | $14.00 | 2022 | |
| Scynexis, INC. | $13.36 | 2022 | |
| Merck Sharp & Dohme LLC | $12.43 | 2021 | |
| Allergan, INC. | $10.90 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Manjit Risam listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.